|
|
 |
|
Viewing report
|
|
|
|
Antares Pharma, Inc.: Company Profile and SWOT Analysis
iCD Research, Dec 2011, Pages: 37
Synopsis
ICD Research's 'Antares Pharma, Inc.: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's 'Antares Pharma, Inc.: Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about 'Antares Pharma, Inc.' for business intelligence requirements
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
- Provides analysis on financial ratios of the company along with a competitor benchmarking section
- The profile also contains information on business operations, company history, major products and services, prospects, key competitors, key employees, locations and subsidiaries
Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Increase business/sales activities by understanding your competitors’ businesses better
- Recognize potential partnerships and suppliers
- Obtain yearly profitability figures
Key Highlights
Antares Pharma, Inc. (Antares Pharma) is a leading developer and marketer of parenteral pharmaceutical products. The company focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. Its subcutaneous injection technology platforms include Vision, reusable needle-free injectors; Vibex, disposable pressure-assisted auto injectors; and disposable multi-use pen injectors. Antares Pharma maintains partnerships with various companies to develop products. In Injector area, the company has multi-product deal with Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. Also, the company has partnership with BioSante Pharmaceuticals, Inc., which includes LibiGel (transdermal testosterone gel) in Phase 3 clinical development for the treatment of female sexual dysfunction. The company's parenteral products division is located in Minneapolis, Minnesota. Antares Pharma is headquartered in Ewing, New Jersey, the US.
|
|
|
|
